Healius Limited (ASX:HLS)
0.8700
+0.0100 (1.16%)
Nov 6, 2025, 4:10 PM AEST
Healius Market Cap
Healius has a market cap or net worth of 631.74 million as of November 6, 2025. Its market cap has decreased by -47.75% in one year.
Market Cap
631.74M
Enterprise Value
1.49B
Revenue
1.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
0.87
Market Cap Chart
Since August 29, 2000, Healius's market cap has increased from 478.57M to 631.74M, an increase of 32.01%. That is a compound annual growth rate of 1.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 631.74M | -36.50% |
| Dec 31, 2024 | 994.80M | -16.20% |
| Dec 29, 2023 | 1.19B | -32.22% |
| Dec 30, 2022 | 1.75B | -43.13% |
| Dec 31, 2021 | 3.08B | 32.57% |
| Dec 31, 2020 | 2.32B | 35.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.76B |
| Pro Medicus | 27.34B |
| Cochlear | 18.57B |
| Sonic Healthcare | 10.34B |
| Ramsay Health Care | 7.27B |
| Telix Pharmaceuticals | 5.35B |
| Ansell | 5.20B |
| Mesoblast | 3.18B |